Murphy Canyon Acquisition Corp. announced that at its EGM held on September 20, 2023, the shareholders approved election of Freda Lewis-Hall, David Tapolczay, James Bligh, Faith L. Charles, Chele Chiavacci Farley, Jennifer I. McNealey, and Andrew Regan as directors of New Conduit. The business combination (the Business Combination), as amended and supplemented, including the Agreement and Plan of Merger, dated as of November 8, 2022 and as amended on January 27, 2023 and May 11, 2023 (the Merger Agreement), by and among the company, Conduit Pharmaceuticals Limited (Conduit) and Conduit Merger Sub Inc. (Merger Sub), which, among other things, provides for the merger of Merger Sub with and into Conduit, with Conduit surviving the merger as a wholly-owned subsidiary of the company.